-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Protein coding genes carry the blueprint for protein production
The length of human pre-mRNA introns varies greatly, ranging from less than 50 nucleotides to more than 1 million nucleotides (nt)
Now, a research team led by Professor Akila Mayeda of the Institute of Comprehensive Medical Sciences at Fujita Health University in Japan is trying to answer this question in the latest research published in Nature Communications
The research team first searched for the necessary factors for splicing human short introns from 154 human nucleoproteins
In HNRNPH1 pre-mRNA with 56-nt intron, the strongest splicing inhibition was caused by SPF45 knockdown, while splicing inhibition was not observed in HNRNPH1 pre-mRNA with control 366-nt intron
Next, the researchers investigated the factors that determine the spf45 dependence of certain short introns
Previously, it has been reported that SPF45 acts as a regulator of alternative splicing; however, SPF45 is also an important factor for cell survival and maintenance in vivo
Professor Mayeda said: "This is a breakthrough achievement in the field of basic research
Original reference:
Title of original paper: SPF45/RBM17-dependent, but not U2AF dependent, splicing in a distinct subset of human short introns
Journal: Nature Communications
DOI: https://doi.